α(2C)-Adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies

Molecular Pharmacology

Volumn 54, Issue 3, 1998, Pages 569-576

  Björklund, Markus ^a   Sirviö, Jouni ^a   Puoliväli, Jukka ^a   Sallinen, Jukka ^b   Jäkälä, Pekka ^a,c   Scheinin, Mika ^b   Kobilka, Brian K ^d   Riekkinen Jr , Paavo ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ADRENERGIC RECEPTOR ALPHA(2C); ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; IMIDAZOLE DERIVATIVE; MEDETOMIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; ELECTROENCEPHALOGRAM; ESCAPE BEHAVIOR; FEMALE; GENE OVEREXPRESSION; KNOCKOUT MOUSE; LEARNING; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SPATIAL DISCRIMINATION; ANIMAL; AVOIDANCE BEHAVIOR; BEHAVIOR; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ESCAPE REACTION; FEMALE; IMIDAZOLES; MEDETOMIDINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION; SPATIAL BEHAVIOR; SPECIES SPECIFICITY;

EID: 0031595683     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.3.569     Document Type: Article

References (39)

1. Annett LE, McGregor A, and Robbins TW (1989) The effects of ibotenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat. Behav Brain Res 31:231-242.
2. 2A-adrenergic receptor-like immunoreactivity. Brain Res 650:181-204.
3. Arnsten AFT and Goldman-Rakic PS (1985) Alpha-2 adrenergic mechanism in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science (Washington DC) 230:1273-1376.
4. Arnsten AFT and Leslie FM (1991) Behavioural and receptor binding analysis of the α-2 adrenergic agonist, UK-14304 (5 bromo-6 (2-imidazoline-2-yl amino) quinoxaline); evidence for cognitive enhancement at an α-2 adrenoceptor subtype. Neuropharmacology 30:1279-1289.
5. 2-noradrenergic mechanisms to prefrontal cortical cognitive function. Arch Gen Psychiatry 53:448-455.
6. Coull JT, Middleton HC, Robbins TW, and Sahakian BJ (1995) Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology (Berl) 120:311-321.
7. 2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type. Psychopharmacology 123:239-249.
8. Crow TJ (1968) Cortical synapses and reinforcement. Nature (Lond) 219:736-737.
9. Fillenz M (1990) Noradrenergic Neurons. Cambridge, Cambridge University Press.
10. Kety SS (1970) The biogenic amines and the central nervous system: their possible roles in arousal, emotion and learning, in The Neurosciences, Second Study Program (Schmidt FO, ed.), pp 324-336, New York, Rockefeller University Press.
11. 2-adrenergic receptor. Science (Washington DC) 238:650-656.
12. 2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42:16-27.
13. 2C-adrenoceptor homolog. Mol Pharmacol 48:48-55.
14. 2-adrenergic receptor subtype, the gene which is located on chromosome 2. Proc Natl Acad Sci USA 87:5094-5098.
15. 2-adrenoceptor-subtype function. Trends Pharmacol Sci 18:211-219.
16. MacDonald E and Scheinin M (1995) Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system. J Physiol Pharmacol 46:241-258.
17. MacDonald E, Scheinin M, Scheinin H, and Virtanen R (1991) Behavioural and neurochemical effects of two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist. J Pharmacol Exp Ther 259:848-854.
18. Marston HM, Everitt BJ, and Robbins TW (1993) Comparative effects of excitotoxic lesions of the hippocampus and septum/diagonal band on conditional visual discrimination and spatial learning. Neuropsychologia 31:1099-1118.
19. Nicholas AP, Hökfelt T, and Pieribone VA (1996) The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol Sci 17:245-255.
20. Nicholas AP, Pieribone V, and Hökfelt, T (1993) Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328:575-594.
21. 2-adrenergic receptor subtype. Proc Natl Acad Sci USA 85:6301-6305.
22. Riekkinen P Jr, Lammintausta R Ekonsalo T, and Sirviö J (1993) The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats. Eur J Pharmacol 238:263-72.
23. Riekkinen P Jr, Sirviö J, Jäkälä P, Lammintausta R, and Riekkinen P (1990) Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis. Neuropharmacology 29:993-999.
24. Riekkinen P Jr, Sirviö J, Riekkinen M, Lammintausta R, and Riekkinen P (1992) Atipamezole, an alpha 2 antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects. Pharmacol Biochem Behav 41:611-614.
25. 2C-adrenergic receptor like immunoreactivity in the rat central nervous system. J Comp Neurol 372:135-165.
26. Sahakian BJ, Coull JT, and Hodges JR (1994) Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 57:120-121.
27. 2C-adrenoceptor agonist. Mol Pharmacol 51:36-46.
28. Samama P, Bond RA, Rockman HA, Milano CA, and Lefkowitz RJ (1997) Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice. Proc Natl Acad Sci USA 94:137-141.
29. 2-adrenoceptors highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. Eur J Pharmacol 195:193-199.
30. Scheel-Krüger J and Willner P (1991) From motivation to action, in The Mesolimbic Dopamine System (Willner P and Scheel-Krüger J, eds), pp 560-597, London, John Wiley & Sons, Ltd.
31. 2-adrenoceptor antagonist. Eur J Pharmacol 151:35-42.
32. Scheinin M, Lomasney JW, Hayden-Hixson DM, Schambra UB, Caron MG, Lefkowitz RJ, and Fremeau RT Jr (1994) Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21:133-149.
33. Simon P, Dupuis R, and Costentin J (1994) Thigmotaxis as an index of anxiety in mice: influence of dopaminergic transmissions. Behav Brain Res 61:59-64.
34. Sirviö J, Riekkinen P Jr, Ekonsalo T, Lammintausta R, and Riekkinen PJ (1992) The effects of dexmedetomidine, an alpha2 agonist, on learning and memory, assessed using passive avoidance and water maze tasks in rats. Neuropharmacology 31: 163-168.
35. Sirviö J, Riekkinen P Jr, Vajanto I, Koivisto E, and Riekkinen PJ (1991) The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task. Behav Neural Biol 56:101-107.
36. Steere JC and Arnsten AFT (1994) The alpha-2 noradrenergic agonist, guanfacine, improves delayed response performance and calms behavior in young monkeys: relevance to attention deficit disorder. Soc Neurosci Abstr 20:831.
37. 2A-adrenergic receptor like immunoreactivity in the rat central nervous system. J Comp Neurol 372:111-134.
38. Thomas RK (1996) Investigating cognitive abilities in animals: unrealized potential. Brain Res Cogn Brain Res 3:157-166.
39. 2-adrenoceptors by atipamezole. Arch Int Pharmacodyn Ther 297:190-204.